107 evolution "https:" "https:" "https:" "ESPCI Paris PSL" positions at Ghent University
Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
setups in which research results can be implemented and evaluated Contributing to the development and writing of new research and project proposals (e.g. FWO, SBO, VLAIO, Horizon Europe, Internal Security
-
Department PS05 - Department of Conflict and Development Studies Degree Masters Diploma Occupancy rate 100% Vacancy type Research staff ABOUT GHENT UNIVERSITY The Conflict Research Group (CRG) , based
-
, United Nations University, ...).https://www.ugent.be/en/research/funding/globalsouthhttps://www.ugent.be/++resource++plone-logo.svg Ghent University actively participates in several development projects, financed
-
of rheumatoid arthritis pathogenesis. Our team has a longstanding interest in external risk factors for arthritis development (PMID: 32080619), in which we have demonstrated that mechanical loading of the joints
-
analysis Opportunities for scientific growth and the development of an independent research line We offer you a contract of definite duration of 1 year. Your contract will start on 1/07/2026 at the earliest
-
evolution of life from ancient Palaeozoic times to the current Anthropocene. The group currently includes a motivated cohort of PhD students, MSc students and postdocs working on various aspects of (micro
-
to the development of seaweed biorefinery scenarios and benchmarks. Improving the assessment of marine and terrestrial biodiversity and ecosystem service impacts within Life Cycle Assessment (LCA), including
-
knowledge and techniques, apply them and distribute them to this end. Depending on the candidate, one can also participate in the development of new methodology in function of the application. Our
-
environmental conditions and the evolution of life from ancient Palaeozoic times to the current Anthropocene. The group currently includes a motivated cohort of PhD students, MSc students and postdocs working
-
Commission will focus on further development of innovative health biotechnological drugs, more specifically mRNA therapeutics. As the science and knowledge service of the European Commission, the Joint